Advertisement

Viral Hepatitis E

  • Shiv K. Sarin
  • Manoj Kumar
Chapter
Part of the Molecular Pathology Library book series (MPLB, volume 5)

Abstract

Hepatitis E virus (HEV) is an enterically transmitted (other routes of transmission may exist) RNA virus that causes an acute, self-limiting hepatitis in immunecompetent subjects, but may also cause chronic infection in immunesuppressed subjects. Infection with HEV may be asymptomatic or may cause hepatitis varying in degree of severity from mild to fulminant disease. Fulminant hepatitis E has been reported with increased frequency in pregnant women.

Keywords

Acute Hepatitis Autochthonous Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. J Med. 1980;68:818–24.Google Scholar
  2. 2.
    Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal–oral route. Intervirology. 1983;20:23–31.PubMedGoogle Scholar
  3. 3.
    Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 1990;247:1335–9.PubMedGoogle Scholar
  4. 4.
    Chandra V, Taneja S, Kalia M, Jameel S. Molecular biology and pathogenesis of hepatitis E virus. J Biosci. 2008;33:451–64.PubMedGoogle Scholar
  5. 5.
    Bradley DW, Andjaparidze AG, Cook Jr EH, et al. Etiologic agent of enterically-transmitted non-A, non-B hepatitis. J Gen Virol. 1988;69:731–8.PubMedGoogle Scholar
  6. 6.
    Emerson SU, Arankalle VA, Purcell RH. Thermal Stability of Hepatitis E Virus. J Infect Dis. 2005;192:930–3.PubMedGoogle Scholar
  7. 7.
    He S et al. Putative receptor-binding sites of hepatitis E virus. J Gen Virol. 2008;89:245–9.PubMedGoogle Scholar
  8. 8.
    Li TC et al. Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J Virol. 2005;79:12999–3006.PubMedGoogle Scholar
  9. 9.
    Xing L et al. Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes. Virology. 1999;265:35–45.PubMedGoogle Scholar
  10. 10.
    Guu TS, Liu Z, Ye Q, Mata DA, Li K, Yin C, et al. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci U S A. 2009;106:12992–7.PubMedGoogle Scholar
  11. 11.
    Wang Y, Zhang H, Ling R, Li H, Harrison TJ. The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3. J Gen Virol. 2000;81:1675–86.PubMedGoogle Scholar
  12. 12.
    Sarin SK, Kumar M. Hepatitis E. In: Boyer T, Manns M, Wright TL, editors. Zakim Boyer’s hepatology: a textbook of liver disease. 5th ed. Philadelphia: Saunders; 2007. p. 693–724.Google Scholar
  13. 13.
    Ropp SL, Tam AW, Beames B, Purdy M, Frey TK. Expression of the hepatitis E virus ORF1. Arch Virol. 2000;145:1321–37.PubMedGoogle Scholar
  14. 14.
    Sehgal D, Thomas S, Chakraborty M, Jameel S. Expression and processing of the hepatitis E virus ORF1 nonstructural polyprotein. Virol J. 2006;3:38.PubMedGoogle Scholar
  15. 15.
    Emerson SU, Zhang M, Meng XJ, Nguyen H, St Claire M, Govindarajan S, et al. Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proc Natl Acad Sci U S A. 2001;98:15270–5.PubMedGoogle Scholar
  16. 16.
    Magden J, Takeda N, Li T, Auvinen P, Ahola T, Miyamura T, et al. Virus-specific mRNA capping enzyme encoded by hepatitis E virus. J Virol. 2001;75:6249–55.PubMedGoogle Scholar
  17. 17.
    Surjit M, Jameel S, Lal SK. Cytoplasmic localization of the ORF2 protein of hepatitis E virus is dependent on its ability to undergo retrotranslocation from the endoplasmic reticulum. J Virol. 2007;81:3339–45.PubMedGoogle Scholar
  18. 18.
    Graff J, Zhou YH, Torian U, Nguyen H, St Claire M, Yu C, et al. Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles. J Virol. 2008;82:1185–94.PubMedGoogle Scholar
  19. 19.
    Surjit M, Jameel S, Lal SK. The ORF2 protein of hepatitis E virus binds the 5′ region of viral RNA. J Virol. 2004;78:320–8.PubMedGoogle Scholar
  20. 20.
    Graff J, Torian U, Nguyen H, Emerson SU. A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. J Virol. 2006;80:5919–26.PubMedGoogle Scholar
  21. 21.
    Emerson SU, Nguyen H, Torian U, Purcell RH. ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro. J Virol. 2006;80:10457–64.PubMedGoogle Scholar
  22. 22.
    Graff J, Nguyen H, Yu C, Elkins WR, St Claire M, Purcell RH, et al. The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques. J Virol. 2005;79:6680–9.PubMedGoogle Scholar
  23. 23.
    Kar-Roy A, Korkaya H, Oberoi R, Lal SK, Jameel S. The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. J Biol Chem. 2004;279:28345–57.PubMedGoogle Scholar
  24. 24.
    Ratra R, Kar-Roy A, Lal SK. The ORF3 protein of hepatitis E virus interacts with hemopexin by means of its 26 amino acid N-terminal hydrophobic domain II. Biochemistry. 2008;47:1957–69.PubMedGoogle Scholar
  25. 25.
    Korkaya H, Jameel S, Gupta D, Tyagi S, Kumar R, Zafrullah M, et al. The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. J Biol Chem. 2001;276:42389–400.PubMedGoogle Scholar
  26. 26.
    Ratra R, Kar-Roy A, Lal SK. ORF3 protein of hepatitis E virus interacts with the Bbeta chain of fibrinogen resulting in decreased fibrinogen secretion from HuH-7 cells. J Gen Virol. 2009;90(Pt 6):1359–70.PubMedGoogle Scholar
  27. 27.
    Moin SM, Panteva M, Jameel S. The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death. J Biol Chem. 2007;282:21124–33.PubMedGoogle Scholar
  28. 28.
    Kannan H, Fan S, Patel D, Bossis I, Zhang YJ. The hepatitis E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics. J Virol. 2009;83(13):6375–82.PubMedGoogle Scholar
  29. 29.
    Tyagi S, Surjit M, Lal SK. The 41-amino-acid C-terminal region of the hepatitis E virus ORF3 protein interacts with bikunin, a kunitz-type serine protease inhibitor. J Virol. 2005;79:12081–7.PubMedGoogle Scholar
  30. 30.
    Surjit M, Oberoi R, Kumar R, Lal SK. Enhanced alpha1 microglobulin secretion from hepatitis E virus ORF3-expressing human hepatoma cells is mediated by the tumor susceptibility gene 101. J Biol Chem. 2006;281:8135–42.PubMedGoogle Scholar
  31. 31.
    Moin SM, Chandra V, Arya R, Jameel S. The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP. Cell Microbiol. 2009;11:1409–21.PubMedGoogle Scholar
  32. 32.
    Yamada K, Takahashi M, Hoshino Y, Takahashi H, Ichiyama K, Nagashima S, et al. ORF3 protein of hepatitis E virus is essential for virion release from infected cells. J Gen Virol. 2009;90(Pt 8):1880–91.PubMedGoogle Scholar
  33. 33.
    He S, Miao J, Zheng Z, Wu T, Xie M, Tang M, et al. Putative receptor-binding sites of hepatitis E virus. J Gen Virol. 2008;89:245–9.PubMedGoogle Scholar
  34. 34.
    Rehman S, Kapur N, Durgapal H, Panda SK. Subcellular localization of hepatitis E virus (HEV) replicase. Virology. 2008;370(1):77–92.PubMedGoogle Scholar
  35. 35.
    Emerson SU, Nguyen H, Graff J, Stephany DA, Brockington A, Purcell RH. In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein. J Virol. 2004;78:4838–46.PubMedGoogle Scholar
  36. 36.
    Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol. 2006;16:5–36.PubMedGoogle Scholar
  37. 37.
    Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology. 1991;185:120–31.PubMedGoogle Scholar
  38. 38.
    Huang CC, Nguyen D, Fernandez J, Yun KY, Fry KE, Bradley DW, et al. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology. 1992;191:550–8.PubMedGoogle Scholar
  39. 39.
    Kwo PY, Schlauder GG, Carpenter HA, Murphy PJ, Rosenblatt JE, Dawson GJ, et al. Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc. 1997;72:1133–6.PubMedGoogle Scholar
  40. 40.
    Okamoto H. Genetic variability and evolution of hepatitis E virus. Virus Res. 2007;127(2):216–28.PubMedGoogle Scholar
  41. 41.
    Wang Y, Ling R, Erker JC, Zhang H, Li H, Desai S, et al. A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis. J Gen Virol. 1999;80:169–77.PubMedGoogle Scholar
  42. 42.
    Takahashi K, Toyota J, Karino Y, Kang JH, Maekubo H, Abe N, et al. Estimation of the mutation rate of hepatitis E virus based on a set of closely related 7.5-year-apart isolates from Sapporo, Japan. Hepatology. 2004;29:212–5.Google Scholar
  43. 43.
    Grandadam M, Tebbal S, Caron M, Siriwardana M, Larouze B, Koeck JL, et al. Evidence for hepatitis E virus quasispecies. J Gen Virol. 2004;85:3189–94.PubMedGoogle Scholar
  44. 44.
    Purcell RH, Emerson SU. Hepatitis E virus. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. p. 3051–61.Google Scholar
  45. 45.
    Shrestha SM, Shrestha S, Tsuda F, Nishizawa T, Takahashi M, Gotanda Y, et al. Genetic changes in hepatitis E virus of subtype 1a in patients with sporadic acute hepatitis E in Kathmandu, Nepal, from 1997 to 2002. J Gen Virol. 2004;85:97–104.PubMedGoogle Scholar
  46. 46.
    Ticehurst J, Rhodes LL, Jr KK, Asher LV, Engler WF, Mensing TL, et al. Infection of owl monkeys (Aotus trivirgatus) and cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus from Mexico. J Infect Dis. 1992;165:835–45.PubMedGoogle Scholar
  47. 47.
    McCaustland KA, Krawczynski K, Ebert JW, Balayan MS, Andjaparidze AG, Spelbring JE, et al. Hepatitis E virus infection in chimpanzees: a retrospective analysis. Arch Virol. 2000;145:1909–18.PubMedGoogle Scholar
  48. 48.
    Williams TP, Kasorndorkbua C, Halbur PG, Haqshenas G, Guenette DK, Toth TE, et al. Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model. J Clin Microbiol. 2001;39:3040–6.PubMedGoogle Scholar
  49. 49.
    Li W, Sun Q, She R, Wang D, Duan X, Yin J, et al. Experimental infection of Mongolian gerbils by a genotype 4 strain of swine hepatitis E virus. J Med Virol. 2009;81(9):1591–6.PubMedGoogle Scholar
  50. 50.
    Huang F, Zhang W, Gong G, Yuan C, Yan Y, Yang S, et al. Experimental infection of Balb/c nude mice with hepatitis E virus. BMC Infect Dis. 2009;9:93.PubMedGoogle Scholar
  51. 51.
    Wei S, Walsh P, Huang R, To SS. 93G, a novel sporadic strain of hepatitis E virus in South China isolated by cell culture. J Med Virol. 2000;61:311–8.PubMedGoogle Scholar
  52. 52.
    Kazachkov Yu A, Balayan MS, Ivannikova TA, Panina LI, Orlova TM, Zamyatina NA, et al. Hepatitis E virus in cultivated cells. Arch Virol. 1992;127:399–402.PubMedGoogle Scholar
  53. 53.
    Meng J, Dubreuil P, Pillot J. A new PCR-based seroneutralization assay in cell culture for diagnosis of hepatitis E. J Clin Microbiol. 1997;35:1373–7.PubMedGoogle Scholar
  54. 54.
    Tanaka T, Takahashi M, Kusano E, Okamoto H. Development and evaluation of an efficient cell-culture system for Hepatitis E virus. J Gen Virol. 2007;88:903–11.PubMedGoogle Scholar
  55. 55.
    Takahashi M, Tanaka T, Azuma M, Kusano E, Aikawa T, Shibayama T, et al. Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system. J Clin Microbiol. 2007;45:3671–9.PubMedGoogle Scholar
  56. 56.
    Prinja S, Kumar S, Reddy GM, Ratho RK, Kumar R. Investigation of viral hepatitis E outbreak in a town in Haryana. J Commun Dis. 2008;40(4):249–54.PubMedGoogle Scholar
  57. 57.
    Clayson ET, Vaughn DW, Innis BL, Shrestha MP, Pandey R, Malla DB. Association of hepatitis E virus with an outbreak of hepatitis at a military training camp in Nepal. J Med Virol. 1998;54:178–82.PubMedGoogle Scholar
  58. 58.
    Rab MA, Bile MK, Mubarik MM, et al. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: a common source outbreak traced to the malfunction of a modern water treatment plant. Am J Trop Med Hyg. 1997;57:151–7.PubMedGoogle Scholar
  59. 59.
    Sedyaningsih-Mamahit ER, Larasati RP, Laras K, et al. First documented outbreak of hepatitis E virus transmission in Java, Indonesia. Trans R Soc Trop Med Hyg. 2002;96:398–404.PubMedGoogle Scholar
  60. 60.
    Isaacson M, Frean J, He J, Seriwatana J, Innis BL. An outbreak of hepatitis E in Northern Namibia, 1983. Am J Trop Med Hyg. 2000;62:619–25.PubMedGoogle Scholar
  61. 61.
    Velazquez O, Stetler HC, Avila C, et al. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986–1987. JAMA. 1990;263:3281–5.PubMedGoogle Scholar
  62. 62.
    Zhuang H, Cao XY, Liu CB, Wang GM. Epidemiology of hepatitis E in China. Gastroenterol Jpn. 1991;26 suppl 3:135–8.PubMedGoogle Scholar
  63. 63.
    Skidmore SJ. Factors in spread of hepatitis E. Lancet. 1999;354:1049–50.PubMedGoogle Scholar
  64. 64.
    Chadha MS, Walimbe AM, Chobe LP, Arankalle VA. Comparison of etiology of sporadic acute and fulminant viral hepatitis in hospitalized patients in Pune, India during 1978–81 and 1994–97. Indian J Gastroenterol. 2003;22:11–5.PubMedGoogle Scholar
  65. 65.
    Arankalle VA, Tsarev SA, Chadha MS, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis. 1995;171:447–50.PubMedGoogle Scholar
  66. 66.
    Tran HT, Ushijima H, Quang VX, et al. Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam. Hepatol Res. 2003;26:275–80.PubMedGoogle Scholar
  67. 67.
    Naik SR, Aggarwal R, Salunke PN, et al. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ. 1992;70:597–604.PubMedGoogle Scholar
  68. 68.
    Mushahwar IK, Dawson GJ, Bile KM, et al. Serological studies of an enterically transmitted non-A, non-B hepatitis in Somalia. J Med Virol. 1993;40:218–21.PubMedGoogle Scholar
  69. 69.
    Aggarwal R, Shahi H, Naik S, et al. Evidence in favour of high infection rate with hepatitis E virus among young children in India. J Hepatol. 1997;26:1425–30.PubMedGoogle Scholar
  70. 70.
    Vishwanathan R. Infectious hepatitis in Delhi (1955–1956): a critical study: epidemiology. Indian J Med Res. 1957;45(suppl):1–29.Google Scholar
  71. 71.
    Khoroo MS, Deurmeyer W, Zargar SA, et al. Acute sporadic non-A, non-B, hepatitis in India. Am J Epidemiol. 1983;118:360–4.Google Scholar
  72. 72.
    Dalton HR, Bendall R, Ijaz S. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008;8(11):698–709.PubMedGoogle Scholar
  73. 73.
    Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988–1994. J Infect Dis. 2009;200(1):48–56.PubMedGoogle Scholar
  74. 74.
    Stoszek SK, Engle RE, Abdel-Hamid M, et al. Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities. Trans R Soc Trop Med Hyg. 2006;100:89–94.PubMedGoogle Scholar
  75. 75.
    Shata MT, Barrett A, Shire NJ, et al. Characterization of hepatitis E specific cell-mediated immune response using IFN-gamma ELISPOT assay. J Immunol Methods. 2007;328:152–61.PubMedGoogle Scholar
  76. 76.
    De Silva AN, Muddu AK, Iredale JP, Sheron N, Khakoo SI, Pelosi E. Unexpectedly high incidence of indigenous acute hepatitis E within south Hampshire: time for routine testing? J Med Virol. 2008;80:283–8.PubMedGoogle Scholar
  77. 77.
    Corwin AL, Tien NT, Bounlu K, et al. The unique riverine ecology of hepatitis E virus transmission in South-East Asia. Trans R Soc Trop Med Hyg. 1999;93:255–60.PubMedGoogle Scholar
  78. 78.
    Somani SK, Aggarwal R, Naik SR, et al. A serological study of intrafamilial spread from patients with sporadic hepatitis E virus infection. J Viral Hepat. 2003;10:446–9.PubMedGoogle Scholar
  79. 79.
    Robson SC, Adams S, Brink N, et al. Hospital outbreak of hepatitis E. Lancet. 1992;339:1424–5.PubMedGoogle Scholar
  80. 80.
    Tsarev SA, Tsarev TS, Emerson SU, et al. Experimental hepatitis E in pregnant rhesus monkeys: failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV. J Infect Dis. 1995;172:31–7.PubMedGoogle Scholar
  81. 81.
    Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet. 1995;345:1025–6.PubMedGoogle Scholar
  82. 82.
    Singh S, Mohanty A, Joshi YK, et al. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr. 2003;70:37–9.PubMedGoogle Scholar
  83. 83.
    Kumar RM, Uduman S, Rana S, et al. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol. 2001;100:9–15.PubMedGoogle Scholar
  84. 84.
    Tschopp A, Joller H, Jeggli S, Widmeier S, Steffen R, Hilfiker S, et al. Hepatitis E, Helicobacter pylori and peptic ulcers in workers exposed to sewage: a prospective cohort study. Occup Environ Med. 2009;66(1):45–50.PubMedGoogle Scholar
  85. 85.
    Casares PC, Pina S, Buti M, et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis. 2003;9:448–54.Google Scholar
  86. 86.
    Vaidya SR, Tilekar BN, Walimbe AM, Arankalle VA. Increased risk of hepatitis E in sewage workers from India. J Occup Environ Med. 2003;45:1167–70.PubMedGoogle Scholar
  87. 87.
    Ceylan A, Ertem M, Ilcin E, Ozekinci T. A special risk group for hepatitis E infection: Turkish agricultural workers who use untreated waste water for irrigation. Epidemiol Infect. 2003;131:753–6.PubMedGoogle Scholar
  88. 88.
    Ng KP, He J, Saw TL, Lyles CM. A seroprevalence study of viral hepatitis E infection in human immunodeficiency virus type 1 infected subjects in Malaysia. Med J Malaysia. 2000;55(1):58–64.PubMedGoogle Scholar
  89. 89.
    Madejón A, Vispo E, Bottecchia M, Sánchez-Carrillo M, García-Samaniego J, Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat. 2009;16:895–6.PubMedGoogle Scholar
  90. 90.
    Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol. 2008;80(2):289–93.PubMedGoogle Scholar
  91. 91.
    Mansuy JM, Huynh A, Abravanel F, Recher C, Peron JM, Izopet J. Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin Infect Dis. 2009;48(3):373–4.PubMedGoogle Scholar
  92. 92.
    Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion. 2008;48(7):1368–75.PubMedGoogle Scholar
  93. 93.
    Fukada S, Sunaga J, Saito N, Fujimura K, Itoh Y, Sasaki M, et al. Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus. J Med Virol. 2004;73:554–61.Google Scholar
  94. 94.
    Yunoki M, Yamamoto S, Tanaka H, Nishigaki H, Tanaka Y, Nishida A, et al. Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofilters. Vox Sang. 2008;95(2):94–100.PubMedGoogle Scholar
  95. 95.
    Toyoda H, Honda T, Hayashi K, Katano Y, Goto H, Kumada T, et al. Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia. Intervirology. 2008;51(1):21–5.PubMedGoogle Scholar
  96. 96.
    Nubling M, Hofmann F, Tiller FW. Occupational risk for hepatitis A and hepatitis E among health care professionals? Infection. 2002;30:94–7.PubMedGoogle Scholar
  97. 97.
    Mitsui T, Tsukamoto Y, Hirose A, Suzuki S, Yamazaki C, Masuko K, et al. Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan. J Med Virol. 2006;78(8):1015–24.PubMedGoogle Scholar
  98. 98.
    Taremi M, Khoshbaten M, Gachkar L, EhsaniArdakani M, Zali M. Hepatitis E virus infection in hemodialysis patients: a seroepidemiological survey in Iran. BMC Infect Dis. 2005;5(1):36.PubMedGoogle Scholar
  99. 99.
    Lee CC, Shih YL, Laio CS, Lin SM, Huang MM, Chen CJ, et al. Prevalence of antibody to hepatitis E virus among haemodialysis patients in Taiwan: possible infection by blood transfusion. Nephron Clin Pract. 2005;99(4):c122–7.PubMedGoogle Scholar
  100. 100.
    Meng XJ. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet Microbiol. 2010;27:256–65.Google Scholar
  101. 101.
    Caron M, Enouf V, Than SC, Dellamonica L, Buisson Y, Nicand E. Identification of genotype 1 hepatitis E virus in samples from swine in Cambodia. J Clin Microbiol. 2006;44:3440–2.PubMedGoogle Scholar
  102. 102.
    Halbur PG, Kasorndorkbua C, Gilbert C, et al. Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J Clin Microbiol. 2001;39:918–23.PubMedGoogle Scholar
  103. 103.
    Chobe LP, Lole KS, Arankalle VA. Full genome sequence and analysis of Indian swine hepatitis E virus isolate of genotype 4. Vet Microbiol. 2006;114:240–51.PubMedGoogle Scholar
  104. 104.
    Meng XJ, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A. 1997;94:9860–5.PubMedGoogle Scholar
  105. 105.
    Schlauder GG, Dawson GJ, Erker JC, et al. The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J Gen Virol. 1998;79:447–56.PubMedGoogle Scholar
  106. 106.
    Arankalle VA, Chobe LP, Joshi MV, Chadha MS, Kundu B, Walimbe AM. Human and swine hepatitis E viruses from western India belong to different genotypes. J Hepatol. 2002;36:417–25.PubMedGoogle Scholar
  107. 107.
    Banks M, Heath GS, Grierson SS, et al. Evidence for the presence of hepatitis E virus in pigs in the United Kingdom. Vet Rec. 2004;154:223–7.PubMedGoogle Scholar
  108. 108.
    Galiana C, Fernández-Barredo S, García A, Gómez MT, Pérez-Gracia MT. Occupational exposure to hepatitis E virus (HEV) in swine workers. Am J Trop Med Hyg. 2008;78(6):1012–5.PubMedGoogle Scholar
  109. 109.
    Bouwknegt M, Engel B, Herremans MM, et al. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in the Netherlands. Epidemiol Infect. 2008;136:567–76.PubMedGoogle Scholar
  110. 110.
    Kase JA, Correa MT, Sobsey MD. Detection and molecular characterization of swine hepatitis E virus in North Carolina swine herds and their faecal wastes. J Water Health. 2009;7(2):344–57.PubMedGoogle Scholar
  111. 111.
    Kasorndorkbua C, Opriessnig T, Huang FF, et al. Infectious swine hepatitis E virus is present in pig manure storage facilities on United States farms, but evidence of water contamination is lacking. Appl Environ Microbiol. 2005;71:7831–7.PubMedGoogle Scholar
  112. 112.
    Matsuda H, Okada K, Takahashi K, Mishiro S. Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar. J Infect Dis. 2003;188:944.PubMedGoogle Scholar
  113. 113.
    Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003;362:371–3.PubMedGoogle Scholar
  114. 114.
    Bouwknegt M, Lodder-Verschoor F, van der Poel WH, Rutjes SA, Roda Husman AM. Hepatitis E virus RNA in commercial porcine livers in the Netherlands. J Food Prot. 2007;70:2889–95.PubMedGoogle Scholar
  115. 115.
    Feagins AR, Opriessnig T, Guenette DK, Halbur PG, Meng XJ. Inactivation of infectious hepatitis E virus present in commercial pig livers sold in local grocery stores in the United States. Int J Food Microbiol. 2008;123:32–7.PubMedGoogle Scholar
  116. 116.
    Dalton HR, Bendall RP, Pritchard C. Pig meat consumption and mortality from chronic liver disease. Gut. 2008;57 suppl 1:A76.Google Scholar
  117. 117.
    Feagins AR, Opriessnig T, Guenette DK, Halbur PG, Meng XJ. Detection and characterization of infectious hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol. 2007;88:912–7.PubMedGoogle Scholar
  118. 118.
    Arankalle VA, Chadha MS, Banerjee K, et al. Hepatitis E virus infection in pregnant rhesus monkeys. Indian J Med Res. 1993;97:4–8.PubMedGoogle Scholar
  119. 119.
    Bradley DW, Krawczynski K, Cook EH, et al. Enterically transmitted non-A, non-B hepatitis: etiology of disease and laboratory studies in non human primates. In: Zukermann AJ, editor. Viral hepatitis and liver disease. New York: Alan R. Liss; 1988. p. 138–47.Google Scholar
  120. 120.
    Chauhan A, Jameel S, Dilawari JB, et al. Hepatitis E virus transmission to a volunteer. Lancet. 1993;341:149–50.PubMedGoogle Scholar
  121. 121.
    Nanda SK, Ansari JH, Acharya SK, et al. Protracted viremia during acute sporadic hepatitis E virus infection. Gastroenterology. 1995;108:225–30.PubMedGoogle Scholar
  122. 122.
    Tsarev SA, Tsareva TS, Emerson SU, et al. Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys. J Med Virol. 1994;43:135–42.PubMedGoogle Scholar
  123. 123.
    Ticehurst J, Rhodes Jr LL, Krawczynski K, et al. Infection of owl monkeys (Aotus trivirgatus) and cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus from Mexico. J Infect Dis. 1992;165:835–45.PubMedGoogle Scholar
  124. 124.
    Soe S, Uchida T, Suzuki K, et al. Enterically transmitted non-A, non-B hepatitis in cynomolgus monkeys: morphology and probable mechanism of hepatocellular necrosis. Liver. 1989;9:135–45.PubMedGoogle Scholar
  125. 125.
    Tsarev SA, Tsareva TS, Emerson SU, et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine. 1997;15:1834–8.PubMedGoogle Scholar
  126. 126.
    Purcell RH, Ticehurst JR. Enterically transmitted non-A, non-B hepatitis: epidemiology and clinical characteristics. In: Zuckerman AJ, editor. Viral hepatitis and liver disease. New York: Allan R Liss Press; 1997. p. 131–7.Google Scholar
  127. 127.
    Pal R, Aggarwal R, Naik SR, Das V, Das S, Naik S. Immunological alterations in pregnant women with acute hepatitis E. J Gastroenterol Hepatol. 2005;20:1094–101.PubMedGoogle Scholar
  128. 128.
    Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007;147:28–33.PubMedGoogle Scholar
  129. 129.
    Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, et al. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol. 2007;22:676–82.PubMedGoogle Scholar
  130. 130.
    Prusty BK, Hedau S, Singh A, Kar P, Das BC. Selective suppression of NF-κ(kappa)Bp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Mol Med. 2007;13:518–26.PubMedGoogle Scholar
  131. 131.
    Favorov MO, Khudyakov YE, Mast EE, et al. IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein. J Med Virol. 1996;50:50–8.PubMedGoogle Scholar
  132. 132.
    Khuroo MS, Kamili S, Dar MY, et al. Hepatitis E and long-term antibody status. Lancet. 1993;341:1355.PubMedGoogle Scholar
  133. 133.
    Zhang S, Tian D, Zhang Z, Xiong J, Yuan Q, Ge S, et al. Clinical significance of anti-HEV IgA in diagnosis of acute genotype 4 hepatitis E virus infection negative for anti-HEV IgM. Dig Dis Sci. 2009;54:2512–8.PubMedGoogle Scholar
  134. 134.
    Wu T, Zhang J, Su ZJ, Liu JJ, Wu XL, Wu XL, et al. Specific cellular immune response in hepatitis E patients. Intervirology. 2008;51(5):322–7.PubMedGoogle Scholar
  135. 135.
    Srivastava R, Aggarwal R, Bhagat MR, Chowdhury A, Naik S. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E. J Viral Hepat. 2008;15(12):910–6.PubMedGoogle Scholar
  136. 136.
    Mast E, Krawczynski K. Hepatitis E: an overview. Ann Rev Med. 1996;47:257.PubMedGoogle Scholar
  137. 137.
    Peron JM, Danjoux M, Kamar N, et al. Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from southwest France. Virchows Arch. 2007;450:405–10.PubMedGoogle Scholar
  138. 138.
    Malcolm P, Dalton H, Hussaini HS, Mathew J. The histology of acute autochthonous hepatitis E virus infection. Histopathology. 2007;51:190–4.PubMedGoogle Scholar
  139. 139.
    Lockwood GL, Fernandez-Barredo S, Bendall R, Banks M, Ijaz S, Dalton HR. Hepatitis E autochthonous infection in chronic liver disease. Eur J Gastroenterol Hepatol. 2008;20:800–3.PubMedGoogle Scholar
  140. 140.
    Haagsma EB, van den Berg AP, Porte RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2008;14:547–53.PubMedGoogle Scholar
  141. 141.
    Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811–7.PubMedGoogle Scholar
  142. 142.
    Gupta DN, Smetana HF. The histopathology of viral hepatitis as seen in the Delhi epidemic (1955–56). Indian J Med Res. 1957;45(suppl):101–13.PubMedGoogle Scholar
  143. 143.
    Khuroo MS, Saleem M, Teli MR, et al. Failure to detect chronic liver disease after epidemic non-A, non-B hepatitis. Lancet. 1980;2:97–8.PubMedGoogle Scholar
  144. 144.
    Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y, Takahashi K, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res. 2007;37(2):113–20.PubMedGoogle Scholar
  145. 145.
    Schildgen O, Müller A, Simon A. Chronic hepatitis E and organ transplants. N Engl J Med. 2008;358:2521–2.PubMedGoogle Scholar
  146. 146.
    Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med. 2009;150(6):430–1.PubMedGoogle Scholar
  147. 147.
    Aggarwal R. Hepatitis E: does it cause chronic hepatitis? Hepatology. 2008;48(4):1328–30.PubMedGoogle Scholar
  148. 148.
    Balayan MS. HEV infection: historical perspectives, global epidemiology, and clinical features. In: Hollinger FB, Lemon SM, Margolis H, editors. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins; 1991. p. 498–501.Google Scholar
  149. 149.
    Sanyal MC. Infectious hepatitis in Delhi (1955–56): a critical study. Observations in armed forces personnel. Indian J Med Res. 1957;45(suppl):91–9.PubMedGoogle Scholar
  150. 150.
    Kumar Acharya S, Kumar Sharma P, Singh R, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007;46:387–94.PubMedGoogle Scholar
  151. 151.
    Kumar M, Sharma BC, Sarin SK. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease. J Gastroenterol Hepatol. 2008;23:883–7.PubMedGoogle Scholar
  152. 152.
    Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, et al. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int. 2009;29(3):392–8.PubMedGoogle Scholar
  153. 153.
    Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat. 2003;10:61–9.PubMedGoogle Scholar
  154. 154.
    Khuroo MS, Khuroo M. Association of severity of HEV infection in the mother and vertically transmitted infection in fetus [letter to Editor, rapid response]. Ann Intern Med. 2007;147:33.Google Scholar
  155. 155.
    Poddar U, Thapa BR, Prasad A, Singh K. Changing spectrum of sporadic acute viral hepatitis in Indian children. J Trop Pediatr. 2002;48:210–3.PubMedGoogle Scholar
  156. 156.
    Kumar A, Yachha SK, Poddar U, Singh U, Aggarwal R. Does co-infection with multiple viruses adversely influence the course and outcome of sporadic acute viral hepatitis in children? J Gastroenterol Hepatol. 2006;21(10):1533–7.PubMedGoogle Scholar
  157. 157.
    Zaki Mel S, Salama OS, Mansour FA, Hossein S. Hepatitis E virus coinfection with hepatotropic viruses in Egyptian children. J Microbiol Immunol Infect. 2008;41(3):254–8.PubMedGoogle Scholar
  158. 158.
    Dixit VK, Abhilash VB, Kate MP, Jain AK. Hepatitis E infection with Bell’s palsy. J Assoc Physicians India. 2006;54:418.PubMedGoogle Scholar
  159. 159.
    Thapa R, Mallick D, Ghosh A. Childhood hepatitis E infection complicated by acute immune thrombocytopenia. J Pediatr Hematol Oncol. 2009;31(2):151.PubMedGoogle Scholar
  160. 160.
    Dalton HR, Stableforth W, Thurairajah P, et al. Autochthonous hepatitis E in southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol. 2008;20:784–90.PubMedGoogle Scholar
  161. 161.
    Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet. 2007;369:1260.PubMedGoogle Scholar
  162. 162.
    Peron JM, Bureau C, Poirson H, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat. 2007;14:298–303.PubMedGoogle Scholar
  163. 163.
    Dalton HR, Fellows HJ, Stableforth W, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther. 2007;26:1429–35.PubMedGoogle Scholar
  164. 164.
    Mizuo H, Yazaki Y, Sugawara K, Tsuda F, Takahashi M, Nishizawa T, et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido. Japan J Med Virol. 2005;76:341–9.Google Scholar
  165. 165.
    Takahashi M, Nishizawa T, Yoshikawa A, Sato S, Isoda N, Ido K, et al. Identification of two distinct genotypes of hepatitis E virus in a Japanese patient with acute hepatitis who had not travelled abroad. J Gen Virol. 2002;83:1931–40.PubMedGoogle Scholar
  166. 166.
    Arankalle VA, Sreenivasan MA, Popper H, et al. Aetiological association of a virus-like particle with enterically transmitted non-A, non-B hepatitis. Lancet. 1988;1:550–4.PubMedGoogle Scholar
  167. 167.
    Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods. 2006;131:65–71.PubMedGoogle Scholar
  168. 168.
    Gyarmati P, Mohammed N, Norder H, et al. Universal detection of hepatitis E virus by two real-time PCR assays: TaqMan and primer-probe energy transfer. J Virol Methods. 2007;146:226–35.PubMedGoogle Scholar
  169. 169.
    Zhao C, Li L, Harrison TJ, Wang Q, Song A, Fan J, et al. Relationships among viral diagnostic markers and markers of liver function in acute hepatitis E. J Gastroenterol. 2009;44(2):139–45.PubMedGoogle Scholar
  170. 170.
    Chen HY, Lu Y, Howard T, et al. Comparison of a new immunochromatographic test to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin M antibodies to hepatitis E virus in human sera. Clin Diagn Lab Immunol. 2005;12:593–8.PubMedGoogle Scholar
  171. 171.
    Lin CC, Wu JC, Chang TT, et al. Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J Clin Microbiol. 2000;38:3915–8.PubMedGoogle Scholar
  172. 172.
    Takahashi M, Kusakai S, Mizuo H, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol. 2005;43:49–56.PubMedGoogle Scholar
  173. 173.
    Zhang JZ, Im SW, Lau SH, et al. Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A, -B, and -C acute hepatitis. J Med Virol. 2002;66:40–8.PubMedGoogle Scholar
  174. 174.
    Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol. 2008;80:95–101.PubMedGoogle Scholar
  175. 175.
    Li RC, Ge SX, Li YP, et al. Seroprevalence of hepatitis E virus infection, rural southern People’s Republic of China. Emerg Infect Dis. 2006;12:1682–8.PubMedGoogle Scholar
  176. 176.
    Yu C, Engle RE, Bryan JP, Emerson SU, Purcell RH. Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay. Clin Diagn Lab Immunol. 2003;10:579–86.PubMedGoogle Scholar
  177. 177.
    Innis BL, Seriwatana J, Robinson RA, et al. Quantitation of immunoglobulin to hepatitis E virus by enzyme immunoassay. Clin Diagn Lab Immunol. 2002;9:639–48.PubMedGoogle Scholar
  178. 178.
    Ferguson M, Walker D, Mast E, Fields H. Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus. Biologicals. 2002;30:43–8.PubMedGoogle Scholar
  179. 179.
    Herremans M, Bakker J, Duizer E, Vennema H. Koopmans MP.Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol. 2007;14:562–8.PubMedGoogle Scholar
  180. 180.
    Tsarev SA, Tsareva TS, Emerson SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A. 1994;91:10198–202.PubMedGoogle Scholar
  181. 181.
    Khuroo MS, Dar MY, Hepatitis E. Evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol. 1992;11:113–6.PubMedGoogle Scholar
  182. 182.
    He J, Kuschner RA, Dewar V, Voet P, Asher LV, Vaughn DW. Characterization of monoclonal antibodies to hepatitis E virus (HEV) capsid protein and identification of binding activity. J Biomed Sci. 2007;14(5):555–63.PubMedGoogle Scholar
  183. 183.
    Wang L, Zhuang H. Hepatitis E: an overview and recent advances in vaccine research. World J Gastroenterol. 2004;10:2157–62.PubMedGoogle Scholar
  184. 184.
    Zhang M, Emerson SU, Nguyen H, Engle RE, Govindarajan S, Gerin JL, et al. Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. Vaccine. 2001;20:853–7.PubMedGoogle Scholar
  185. 185.
    Safary A. Perspectives of vaccination against hepatitis E. Intervirology. 2001;44:162–6.PubMedGoogle Scholar
  186. 186.
    Shrestha MP, Scott RM, Joshi DM, Mammen Jr MP, Thapa GB, Thapa N, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007;356:895–903.PubMedGoogle Scholar
  187. 187.
    Arankalle VA, Lole KS, Deshmukh TM, Srivastava S, Shaligram US. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes. Vaccine. 2009;27(7):1032–9.PubMedGoogle Scholar
  188. 188.
    Purcell RH, Nguyen H, Shapiro M, Engle RE, Govindarajan S, Blackwelder WC, et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine. 2003;21:2607–15.PubMedGoogle Scholar
  189. 189.
    Krawczynski K. Hepatitis E vaccine – ready for prime time? N Engl J Med. 2007;356:949–51.PubMedGoogle Scholar
  190. 190.
    Tacke F, Trautwein C. Efficient recombinant hepatitis E virus vaccine: mission accomplished? Hepatology. 2007;46(3):941–3.PubMedGoogle Scholar
  191. 191.
    Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine. 2005;23:2893–901.PubMedGoogle Scholar
  192. 192.
    Zhang JZ, Ng MH, Xia NS, Lau SH, Che XY, Chau TN, et al. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol. 2001;64:125–32.PubMedGoogle Scholar
  193. 193.
    Li SW, Zhang J, He ZQ, Gu Y, Liu RS, Lin J, et al. Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J Biol Chem. 2005;280:3400–6.PubMedGoogle Scholar
  194. 194.
    Zhang J, Gu Y, Ge SX, Li SW, He ZQ, Huang GY, et al. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine. 2005;23:2881–92.PubMedGoogle Scholar
  195. 195.
    Wu T, Wu XL, Ou SH, Lin CX, Cheng T, Li SW, et al. Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity. Mol Immunol. 2007;44:3261–6.PubMedGoogle Scholar
  196. 196.
    Ge S, Zhang J, Huang G, Pang S, Zhou K, Xia N. The immuno-protect study of a hepatitis E virus ORF2 peptide expressed in E. coli. Wei Sheng Wu Xue Bao. 2003;43:35–42.PubMedGoogle Scholar
  197. 197.
    Zhang J, Liu CB, Li RC, Li YM, Zheng YJ, Li YP, et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine. 2009;27(12):1869–74.PubMedGoogle Scholar
  198. 198.
    Rose SR, Keystone JS. Hepatitis. In: International Travel Health Guide: 2007 Online Edition. At <www.travmed.com/health_guide/ch12.htm>. Accessed 12 Jan 2010.

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of GastroenterologyG.B. Pant HospitalNew DelhiIndia
  2. 2.Institute of Liver and Biliary SciencesNew DelhiIndia

Personalised recommendations